Two Sorafenib (Nexavar) Clinical Trials are Currently Recruiting Sarcoma Patients in Different Locations Across the USA
1. Phase II Study of Sorafenib in Patients With Advanced Soft Tissue Sarcomas 2. Sorafenib in Treating Patients With Soft Tissue Sarcomas Alveolar Soft Part Sarcoma (ASPS) is highly angiogenic: it involves intensive growth of new blood vessels into the tumor. Those blood vessels connect the tumor to the blood system, supply oxygen and nutrients […]